Bioprocessing White Papers

31. Accelerate Lead Times Through Seamless External Collaboration In Quality 5/21/2026

    As CDMO networks expand, disconnected quality processes create delays and risk. Learn how seamless external collaboration improves visibility, accelerates approvals, and strengthens sponsor–partner relationships—helping teams move faster without compromising compliance.

32. An Innovative, Modular Approach To Flexible Supply Chain Management 5/15/2026

    Learn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.

33. Effect of Shelf Cooling Rate on the Nucleation Temperature of Ice Monitored Using Thermocouples and Wireless Temperature Sensors 5/14/2026

    Freezing conditions shape ice structure, mass transfer resistance, and drying efficiency. Data shows how cooling rate, vial size, and nucleation interact to optimize freeze-drying.

34. Practical Considerations For Your Process Characterization Study 5/14/2026

    Outsourced process characterization can save time, but only with the right preparation. Clear expectations around materials and data interpretation help reduce rework and strengthen confidence.

35. How Integration Is Redefining Speed, Scale, And Sustainability 5/13/2026

    Integrated manufacturing ecosystems help biologics programs adapt to changing demand across the product lifecycle. Discover flexible scaling strategies that improve speed, efficiency, and sustainability.

36. A Practical Guide To Expanding Across Sites While Staying Compliant 5/13/2026

    Standardizing governance and data foundations is critical for scaling multi-site networks without increasing risk. Learn to leverage reusable validation and harmonized workflows for audit readiness.

37. Accelerating An Innovative High Potency Oncology Therapy To Market 5/13/2026

    Learn how disciplined containment, proactive risk management, and collaboration accelerate complex oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

38. Unlocking Durable Allogeneic Cell Therapy 5/13/2026

    Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

39. Accelerating ADC Analytical Method Development Through Platform Innovation 5/11/2026

    Leverage a platform-based analytical development strategy to accelerate ADC IND readiness through early CQA identification, reduced development risk, and streamlined progression from development to patients.

40. (Cross-) Contamination Control Through Effective Equipment Cleaning 5/6/2026

    Discover science-driven cleaning strategies that reduce cross-contamination, enable safe multiproduct manufacturing, and support faster, flexible GMP changeovers.